The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Abstract
A long-standing paradox in cellular immunology concerns the conditional requirement for CD4+ T-helper (T(H)) cells in the priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4+ T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T(H) cells. A clearer understanding of the contribution of T(H) cells to CTL development has been hampered by the fact that most T(H)-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T(H)-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T(H)-dependent and T(H)-independent CTLs and find in both cases that CD4+ T cells are dispensable for primary expansion of CD8+ T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T(H) cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter cell death is mediated by expression of the death ligand TRAIL, which triggers apoptosis in the helpless CTL as well as other activated T cells70,72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“In support of this, TRAIL-deficient mice were resistant to tolerance induction by intravenously injected apoptotic cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“As a result, the CD8+ T cells produce TRAIL upon re-exposure to antigen, which acts to inhibit immunization for cell-mediated responses (that is, mediate tolerance).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“DC that have engulfed necrotic cells present antigen to both CD4+ and CD8+ T cells, however those that engulf apoptotic cells present antigen to CD8+ T cells but not CD4+ T cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citationA conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Although transition through these stages was thought to be governed by the presence and eventual elimination of antigen, mounting evidence suggests that CD8 p T-cell development is guided by an instructional programme that, once set into motion during priming, is executed independentl”
BackgroundDialynas, D. P., Quan, Z., Wall, K. A., Pierrès, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,265
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 843
Self-citationT Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 739
Cited by
Sorted by citations
Items 801–900 of 1,000
Shimizu, K., Asakura, M., & Fujii, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003351 · Cited by 26
Wong, S. B. J., Buck, C. B., Shen, X., & Siliciano, R. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3073 · Cited by 26
Natural Regulation of Immunity to Minor Histocompatibility Antigens
Robertson, N. J., Chai, J., Millrain, M., Scott, D. M., Hashim, F., Manktelow, E., Lemonnier, F. A., Simpson, E., & Dyson, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3558 · Cited by 26
Role of interleukin-21 in HBV infection: friend or foe?
Li, Y., Tang, L., & Hou, J. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.109 · Cited by 26
Homan, E. J., & Bremel, R. D. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27139 · Cited by 26
Role of Integrin CD103 in Promoting Destruction of Renal Allografts by CD8+ T Cells
Hadley, G. A. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00465.x · Cited by 26
Kumaraguru, U., Suvas, S., Biswas, P. S., Azkur, A. K., & Rouse, B. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3719 · Cited by 26
Dendritic Cell–Based Vaccination Against Cancer
Saito, H., Frleta, D., Dubsky, P. C., & Palucka, K. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.02.011 · Cited by 27
Antigen-specific CD4+ regulatory T cells in cancer: implications for immunotherapy
Wang, H. Y., & Wang, R. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.028 · Cited by 26
Bassi, M. R., Larsen, M. A. B., Kongsgaard, M., Rasmussen, M., Buus, S., Stryhn, A., Thomsen, A. R., & Christensen, J. P. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004464 · Cited by 25
Thomas, P. G., Brown, S. A., Morris, M. Y., Yue, W. W., So, J., Reynolds, C., Webby, R. J., & Doherty, P. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901427 · Cited by 25
Hu, Z., Molloy, M. J., & Usherwood, E. J. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.128 · Cited by 26
CD4+ T-Cell Response to MitochondrialCytochrome bin Human Melanoma
Voo, K. S., Zeng, G., Mu, J., Zhou, J., Su, X., & Wang, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4574 · Cited by 25
Translating insights from persistent LCMV infection into anti-HIV immunity
Wilson, E. B., & Brooks, D. G. (2010) · Immunologic Research · doi:10.1007/s12026-010-8162-1 · Cited by 25
Lu, Z., Condomines, M., Tarte, K., Nadal, L., Delteil, M. C., Rossi, J. F., Ferrand, C., & Klein, B. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.002 · Cited by 25
Mercier‐Letondal, P., Deschamps, M., Sauce, D., Certoux, J. M., Milpied, N. J., Lioure, B., Cahn, J.-Y. Y., Deconinck, É., Ferrand, C., Tiberghien, P., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.156 · Cited by 25
Immunology of Hematopoietic Stem Cell Transplant
Mosaad, Y. M. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.942460 · Cited by 25
Huebener, N., Fest, S., Hilt, K., Schramm, A. R., Eggert, A., Durmus, T., Woehler, A., Stermann, A., Bleeke, M., Baykan, B., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0107 · Cited by 25
Vaccination against Lymphocytic Choriomeningitis Virus Infection in MHC Class II-Deficient Mice
Holst, P. J., Christensen, J. P., & Thomsen, A. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001251 · Cited by 25
Kawahara, M., & Takaku, H. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1078027 · Cited by 26
Liver sinusoidal endothelial cell cross-priming is supported by CD4 T cell-derived IL-2
Wittlich, M. M., Dudek, M., Böttcher, J. P., Schanz, O., Hegenbarth, S. I., Bopp, T., Schmitt, E., Kurts, C., Garbers, C., Rose‐John, S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.015 · Cited by 26
Maksimow, M., Miiluniemi, M., Marttila‐Ichihara, F., Jalkanen, S., & Hänninen, A. L. M. (2006) · Blood · doi:10.1182/blood-2005-11-008615 · Cited by 25
Lin, C., Chang, T.-C., Shaw, S., Cheng, P., Huang, C., Chao, A., Soong, Y., & Lai, C. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.108 · Cited by 25
Kobayashi, H., Omiya, R., Sodey, B., Yanai, M., Oikawa, K., Sato, K., Kimura, S., Senju, S., Nishimura, Y., Tateno, M., et al. (2003) · PubMed · Cited by 25
Activation-Induced CD154 Expression Abrogates Tolerance Induced by Apoptotic Cells
Gurung, P., Kucaba, T. A., Ferguson, T. A., & Griffith, T. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901676 · Cited by 26
Piriou, E., van Dort, K. A., Nanlohy, N. M., van Oers, M. H. J., Miedema, F. F., & van Baarle, D. (2005) · European Journal of Immunology · doi:10.1002/eji.200425792 · Cited by 25
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial
D’Alise, A. M., Willis, J. A., Düzağaç, F., Hall, M. J., Cruz–Correa, M., Idos, G., Thirumurthi, S., Ballester, V., Leoni, G., Garzia, I., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04182-9 · Cited by 27
Allogeneic transplantation as anticancer immunotherapy
Parmar, S., & Ritchie, D. S. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.010 · Cited by 24
Longitudinal Requirement for CD4+ T Cell Help for Adenovirus Vector–Elicited CD8+ T Cell Responses
Provine, N. M., Larocca, R. A., Penaloza‐MacMaster, P., Borducchi, E. N., McNally, A. G., Parenteau, L. R., Kaufman, D. R., & Barouch, D. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302806 · Cited by 24
Distinct Kinetics of Gag-Specific CD4+ and CD8+ T Cell Responses during Acute HIV-1 Infection
Riou, C., Ganusov, V. V., Campion, S., Mlotshwa, M., Liu, M. K. P., Whale, V., Goonetilleke, N. P., Borrow, P., Ferrari, G., Betts, M. R., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102813 · Cited by 24
Laher, F., Ranasinghe, S., Porichis, F., Mewalal, N., Pretorius, K., Ismail, N., Buus, S., Stryhn, A., Carrington, M. N., Walker, B. D., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02477-16 · Cited by 24
Brito, M. J., Sequeira, P., Silva, I., Quintas, A., Martins, C. G., & Félix, A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.083 · Cited by 24
Kinetic and Mechanistic Requirements for Helping CD8 T Cells
Agnellini, P., Wiesel, M., Schwarz, K., Wolint, P., Bachmann, M. F., & Oxenius, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1517 · Cited by 24
Zheng, Y., Huang, Z., Chen, X., Tian, Y., Tang, J., Zhang, Y., Zhang, X., Zhou, J., Mao, Q., Ni, B., et al. (2012) · Mediators of Inflammation · doi:10.1155/2012/789859 · Cited by 24
Phenotypic characterization of autoreactive T cells in multiple sclerosis
Ratts, R. B., Karandikar, N. J., Hussain, R. Z., Choy, J., Northrop, S. C., Lovett‐Racke, A. E., & Racke, M. K. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.010 · Cited by 24
Heterospecific CD4 Help to Rescue CD8 T Cell Killers
de Herve, M.-G. D. G., Cariou, A., Simonetta, F., & Taoufik, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5974 · Cited by 25
The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy
Amara, S., & Tiriveedhi, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030650 · Cited by 24
Stock, S., Hoffmann, J., Schubert, M., Wang, L., Wang, S., Gong, W., Neuber, B., Gern, U., Schmitt, A., Müller‐Tidow, C., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.237 · Cited by 24
Blockade of Virus Infection by Human CD4+ T Cells via a Cytokine Relay Network
Davis, A. M., Hagan, K. A., Matthews, L. A., Bajwa, G., Gill, M. A., Gale, M., & Farrar, J. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6923 · Cited by 24
Heit, A., Gebhardt, F. E., Lahl, K., Neuenhahn, M., Schmitz, F., Anderl, F., Wagner, H., Sparwasser, T. D., Busch, D. H., & Kastenmüller, K. (2008) · European Journal of Immunology · doi:10.1002/eji.200737966 · Cited by 24
Stevenson, F. K. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000181406.60213.c7 · Cited by 24
In Vivo Impact of CpG1826 Oligodeoxynucleotide on CD8 T Cell Primary Responses and Survival
Belœil, L., Tomkowiak, M., Angelov, G. S., Walzer, T., Dubois, P. M., & Marvel, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2995 · Cited by 24
Long-Term Functionality of TCR-Transduced T Cells In Vivo
Coccoris, M., Swart, E., de Witte, M. A., van Heijst, J. W. J., Haanen, J. B. A. G., Schepers, K., & Schumacher, T. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6536 · Cited by 24
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor
Zhou, H., Luo, Y., Kaplan, C., Krüger, J. A., Lee, S., Xiang, R., & Reisfeld, R. A. (2005) · Blood · doi:10.1182/blood-2005-10-4231 · Cited by 24
In Vitro Human Memory CD8 T Cell Expansion in Response to Cytomegalovirus Requires CD4+T Cell Help
Salkowitz, J. R., Sieg, S. F., Harding, C. V., & Lederman, M. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/382032 · Cited by 24
Heeney, J. L. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.s53 · Cited by 24
Somogyi, E., Xu, J., Gudics, Á., Tóth, J., Kovács, A., Lori, F., & Lisziewicz, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.019 · Cited by 23
Hou, X., Shi, Y., Kang, X., Rousu, Z., Li, D., Wang, M., Ainiwaer, A., Zheng, X., Wang, M., Jiensihan, B., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.983119 · Cited by 23
Mo, F., Watanabe, N., Omdahl, K. I., Burkhardt, P. M., Ding, X., Hayase, E., Panoskaltsis‐Mortari, A., Jenq, R. R., Heslop, H. E., Kean, L. S., et al. (2022) · Blood · doi:10.1182/blood.2022016052 · Cited by 23
Yi, Q., Wang, J., Liu, T., Yao, Y., Loveless, I. M., Subedi, K., Toor, J. S., Adrianto, I., Xiao, H. F., Chen, B., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216149 · Cited by 23
Differential Effects of Dendritic Cell Transfer on Airway Hyperresponsiveness and Inflammation
Koya, T., Matsuda, H., Matsubara, S., Miyahara, N., Dakhama, A., Takeda, K., & Gelfand, E. W. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0256oc · Cited by 23
Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses
Imami, N., Westrop, S. J., Grageda, N., & Herasimtschuk, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00058 · Cited by 25
Sui, Y., Gagnon, S. J., Dzutsev, A. H., Zhu, Q., Yu, H., Hogg, A. E., Wang, Y., Xia, Z., Belyakov, I. M., Venzon, D. J., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.043 · Cited by 23
Opposing positive and negative regulation of T cell activity during viral persistence
Fahey, L. M., & Brooks, D. G. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.03.004 · Cited by 23
Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers
Groß, S., Lennerz, V., Gallerani, E., Mach, N., Böhm, S., Hess, D., von Boehmer, L., Knuth, A. K., Ochsenbein, A. F., Gnad-Vogt, U., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0105 · Cited by 23
Wang, S., Yang, G., Nie, J., Yang, R.-J., Du, M., Su, J.-H., Wang, J., Wang, J., & Zhu, Y. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.03.020 · Cited by 23
Alatery, A., Siddiqui, S., Chan, M., Kuś, A., Petrof, E., & Basta, S. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2009.90 · Cited by 25
Multivalent DNA Vaccine Enhanced Protection Efficacy against Infectious Bronchitis Virus in Chickens
Tai, Y. A. N. G., Wang, H., Wang, X., Tang, J., Gao, R., Li, J., Zi-Cheng, G. U. O., & Yu-Ling, L. I. (2009) · Journal of Veterinary Medical Science · doi:10.1292/jvms.001585 · Cited by 23
T cells and dendritic cells in glomerular disease: the new glomerulotubular feedback loop
Sung, S. J., & Bolton, W. K. (2009) · Kidney International · doi:10.1038/ki.2009.489 · Cited by 23
Serre, K., Giraudo, L., Siret, C., Leserman, L., & Machy, P. (2006) · European Journal of Immunology · doi:10.1002/eji.200526193 · Cited by 25
Correa‐Rocha, R., Harari, A., Vallelian, F., Resino, S., Muñoz‐Fernández, M. Á., & Pantaleo, G. (2006) · AIDS · doi:10.1097/qad.0b013e32801120bc · Cited by 23
The Regulation and Maturation of Antiviral Immune Responses
Whitton, J. L., Slifka, M. K., Liu, F., Nussbaum, A. K., & Whitmire, J. K. (2004) · Advances in virus research · doi:10.1016/s0065-3527(04)63003-x · Cited by 23
Hsueh, E. C., Famatiga, E., Shu, S. T., Ye, X., & Morton, D. L. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.02.018 · Cited by 23
Rapetti, L., Meunier, S., Pontoux, C., & Tanchot, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.299 · Cited by 24
Yang, K., Sun, K., Srinivasan, K. N., Salmon, J., Marques, E. T. A., Xu, J., & August, J. T. (2009) · Gene Therapy · doi:10.1038/gt.2009.92 · Cited by 22
Driessens, G., Gordower, L., Nuttin, L., Stordeur, P., Blocklet, D., Egrise, D., Velu, T. J., & Bruyns, C. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0500-y · Cited by 22
Shiina, M., Rehermann, B., Jaeschke, H., Mullen, K., & Moradpour, D. (2006) · Hepatology · doi:10.1002/hep.21210 · Cited by 23
Zhang, X., & Starnbach, M. N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500457 · Cited by 22
Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Wei, H., Wang, H., Lü, B., Li, B., Hou, S., Qian, W., Fan, K., Dai, J., Zhao, J., & Guo, Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6051 · Cited by 22
Kobayashi, Y., Sakura, T., Miyawaki, S., Toga, K., Sogo, S., & Heike, Y. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1981-3 · Cited by 22
Pearce, H., Hutton, P., Chaudhri, S., Porfiri, E., Patel, P., Viney, R., & Moss, P. A. H. (2017) · European Journal of Immunology · doi:10.1002/eji.201646898 · Cited by 22
Cai, D., Song, Q., Duan, C., Wang, S., Wang, J., & Zhu, Y. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.054 · Cited by 22
Building better T‐cell‐inducing malaria vaccines
Todryk, S. M., & Walther, M. R. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02154.x · Cited by 22
Does programmed CTL proliferation optimize virus control?
Wodarz, D., & Thomsen, A. R. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.007 · Cited by 22
Fujiki, F., Oka, Y., Kawakatsu, M., Tsuboi, A., Nakajima, H., Elisseeva, O. A., Harada, Y., Li, Z., Tatsumi, N., Kamino, E., et al. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00080.x · Cited by 22
Toka, F. N., Gieryńska, M. M., Suvas, S., Schoenberger, S. P., & Rouse, B. T. (2004) · Virology · doi:10.1016/j.virol.2004.10.022 · Cited by 22
Self-citationKo, E. C., Luo, W., Peng, L., Wang, X., & Ferrone, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1744 · Cited by 22
Linked Foreign T-Cell Help Activates Self-Reactive CTL and Inhibits Tumor Growth
Steinaa, L., Rasmussen, P. B., Wegener, A. M., Sonderbye, L., Leach, D. R., Rygaard, J., Mouritsen, S., & Gautam, A. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.329 · Cited by 22
Altes, H. K., Ribeiro, R. M., & de Boer, R. J. (2003) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2003.2377 · Cited by 22
Lian, Z., Gibson, T. F., Schechner, J. S., Pober, J. S., & Bothwell, A. L. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3020 · Cited by 22
Disease-driven T cell activation predicts immune responses to vaccination against melanoma.
Speiser, D. E., Rimoldi, D., Batard, P., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2003) · PubMed · Cited by 22
Stevenson, F. K., Rice, J., & Zhu, D. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82002-9 · Cited by 22
Zitti, B., Duval, F., Wirapati, P., Hicham, M., Xie, Y., Oh, J., Hoelzl, J., Meiser, P., Varrone, M., Peterson, H. M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.11.020 · Cited by 22
DNA fusion vaccines enter the clinic
Stevenson, F. K., Mander, A., Chudley, L., & Ottensmeier, C. H. H. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1042-2 · Cited by 21
Humanized Mouse Models to Study Cell-Mediated Immune Responses to Liver-Stage Malaria Vaccines
Good, M. F., Hawkes, M., & Yanow, S. K. (2015) · Trends in Parasitology · doi:10.1016/j.pt.2015.06.008 · Cited by 21
Ip, P. P., Boerma, A., Walczak, M., Oosterhuis, K., Haanen, J. B. A. G., Schumacher, T. N., Nijman, H. W., & Daemen, T. (2015) · Gene Therapy · doi:10.1038/gt.2015.24 · Cited by 21
Tran, K. K., Zhan, X., & Shen, H. Y. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300306 · Cited by 21
Schmueck‐Henneresse, M., Fischer, A. M., Hammoud, B., Brestrich, G., Fuehrer, H., Luu, S.-H., Mueller, K., Babel, N., Volk, H., & Reinke, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103763 · Cited by 21
Herasimtschuk, A., Westrop, S. J., Moyle, G. J., Downey, J. S., & Imami, N. (2008) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-6-7 · Cited by 21
Memory programming in CD8+ T-cell differentiation is intrinsic and is not determined by CD4 help
Kim, J., Ryu, S. J., Oh, K., Ju, J.-M., Jeon, J. Y., Nam, G., Lee, D., Kim, H., Kim, J., Chang, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8994 · Cited by 21
State-of-Art of Cellular Therapy for Acute Leukemia
Lee, J. B., Vasić, D., Kang, H., Fang, K., & Li, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094590 · Cited by 22
Principles of Memory CD8 T-Cells Generation in Relation to Protective Immunity
Zanetti, M., Castiglioni, P., & Ingulli, E. G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_9 · Cited by 21
CD11c: Not merely a murine DC marker, but also a useful vaccination target
Kurts, C. (2008) · European Journal of Immunology · doi:10.1002/eji.200838645 · Cited by 23
Grujić, M., Holst, P. J., Christensen, J. P., & Thomsen, A. R. (2009) · Journal of General Virology · doi:10.1099/vir.0.002105-0 · Cited by 21
Landry, S. J. (2007) · Journal of Virology · doi:10.1128/jvi.02026-07 · Cited by 21
Jones, R. B., Yue, F., Gu, X. X. J., Hunter, D. V., Mujib, S., Gyenes, G. T., Mason, R. D., Mohamed, R., MacDonald, K. S., Kovacs, C. M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00433-09 · Cited by 21
The Cooperation between Two CD4 T Cells Induces Tumor Protective Immunity in MUC.1 Transgenic Mice
Gerloni, M., Castiglioni, P., & Zanetti, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6551 · Cited by 21
Adoptive Cellular Therapy (ACT) for Cancer Treatment
Yang, F., Jin, H., Wang, J., Sun, Q., Yan, C., Wei, F., & Ren, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7555-7_4 · Cited by 21
Kyte, J. A., Gaudernack, G., Faane, A., Lislerud, K., Inderberg, E. M., Brunsvig, P. F., Aamdal, S., Kvalheim, G., Wälchli, S., & Pulè, M. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1249090 · Cited by 22
Choudhury, A., Maldonado, M. A., Cohen, P. L., & Eisenberg, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7600 · Cited by 21
Metadata
- Authors
- Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Corresponding author
- Schoenberger, Stephen P.
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6925
- Pages
- 852-856
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1493822493
- Cited by
- 1,635
- References
- 28
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 37 · 2023: 46 · 2022: 37 · 2021: 42 · 2020: 58 · 2019: 42 · 2018: 52 · 2017: 36 · 2016: 41 · 2015: 61 · 2014: 63 · 2013: 63 · 2012: 71
- FWCI
- 46.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- CD4+ T cells, CD8+ T cells, cytotoxic T lymphocytes, T helper cells, secondary immune response, T cell memory, T cell help, cross-priming, antigen-presenting cells, T cell differentiation
- MeSH terms
- Animals, Antigens, Cell Line, Cytotoxicity, Immunologic, Flow Cytometry, T-Lymphocytes, Helper-Inducer, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, T-Lymphocytes, Cytotoxic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review